Bounds on potential risks and causal risk differences under assumptions about confounding parameters
- 24 May 2007
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 26 (28), 5125-5135
- https://doi.org/10.1002/sim.2927
Abstract
Nonparametric bounds on causal effects in observational studies are available under deterministic potential-outcome models. We derive narrower bounds by adding assumptions regarding bias due to confounding. This bias is defined as the difference between the expectation of potential outcomes for the exposed group and that for the unexposed group. We show that crude effect measures bound causal effects under the given assumptions. We then derive bounds for randomized studies with noncompliance, which are given by the per protocol effect. With perfect compliance in one treatment group, the direction of effect becomes identifiable under our assumptions. Although the assumptions are not themselves identifiable, they are nonetheless reasonable in some situations. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Instruments for Causal InferenceEpidemiology, 2006
- Bounding Causal Effects Under Uncontrolled Confounding Using CounterfactualsEpidemiology, 2005
- Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measuresStatistics in Medicine, 2004
- The Impact of Prior Distributions for Uncontrolled Confounding and Response BiasJournal of the American Statistical Association, 2003
- Using Information on Realized Effects to Determine Prospective Causal EffectsJournal of the Royal Statistical Society Series B: Statistical Methodology, 2001
- Bounds on Treatment Effects from Studies with Imperfect ComplianceJournal of the American Statistical Association, 1997
- Causal inference from indirect experimentsArtificial Intelligence in Medicine, 1995
- Intention-to-treat analysis and the goals of clinical trials*Clinical Pharmacology & Therapeutics, 1995
- On estimating efficacy from clinical trialsStatistics in Medicine, 1991
- Marginal likelihoods based on Cox's regression and life modelBiometrika, 1973